26P Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

J. Samol, I. Demedts, M. Erman, V. Kozlov, J.N. Minatta, F.V. Moiseenko, M.S. Paats, S.J. Rajappa, T. Bailey, H. Wallis, M. Madondo, D. Kahangire, M. Zukin

JOURNAL OF THORACIC ONCOLOGY(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要